S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
NASDAQ:GRI

GRI Bio (GRI) Stock Price, News & Analysis

0.38
0.00 (-1.00%)
(As of 12/29/2023 09:01 PM ET)
Today's Range
0.35
0.40
50-Day Range
0.33
1.27
52-Week Range
0.32
36.90
Volume
284,700 shs
Average Volume
671,557 shs
Market Capitalization
$1.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GRI stock logo

About GRI Bio Stock (NASDAQ:GRI)

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention-deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in Philadelphia, Pennsylvania.

GRI Stock Price History

GRI Stock News Headlines

GRI Bio, Inc. (NASDAQ:GRI) Short Interest Up 194.2% in December
New Year's Sale: Get MarketBeat All Access Free For 30 Days
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscription
GRI Bio Inc GRI
GRI Bio reports Q3 results
Claim Your $300 MarketBeat Account Credit
Click the link below to claim your $300.00 account credit toward MarketBeat All Access. Pay just $99.00 for your 2024 MarketBeat All Access subscription (normally $399.00)
See More Headlines
Receive GRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GRI Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
12/31/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/23/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GRI
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Net Income
$-7,020,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100,000.00
Book Value
5.52 per share

Miscellaneous

Free Float
3,376,000
Market Cap
$1.74 million
Optionable
Not Optionable
Beta
-1.53
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. W. Marc Hertz Ph.D. (Age 53)
    Co-Founder, CEO, President & Director
  • Dr. Vipin Kumar Chaturvedi Ph.D. (Age 64)
    Co-Founder & Chief Scientific Officer
  • Ms. Leanne M. Kelly (Age 46)
    CFO & Corporate Secretary
  • Dr. Albert Agro Ph.d. (Age 58)
    Chief Medical Officer














GRI Stock Analysis - Frequently Asked Questions

How have GRI shares performed in 2023?

GRI Bio's stock was trading at 7.36 at the beginning of the year. Since then, GRI stock has decreased by 94.8% and is now trading at 0.39.
View the best growth stocks for 2023 here
.

When is GRI Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 23rd 2024.
View our GRI earnings forecast
.

How were GRI Bio's earnings last quarter?

GRI Bio, Inc. (NASDAQ:GRI) announced its earnings results on Tuesday, November, 14th. The company reported ($0.52) earnings per share for the quarter.

When did GRI Bio's stock split?

Shares of GRI Bio reverse split on the morning of Monday, April 24th 2023. The 1-30 reverse split was announced on Monday, April 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, April 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of GRI Bio?

Shares of GRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRI) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -